US · Healthcare

Kintor Pharmaceutical Limited (KNTPF)

Biotechnology

Kintor Pharmaceutical Limited (KNTPF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KNTPF

P/E ratio

18.00

Kintor Pharmaceutical Limited (KNTPF) — FAQ

What is KNTPF's P/E ratio?

The price-to-earnings (P/E) ratio for Kintor Pharmaceutical Limited (KNTPF) is 18.00 (data as of 2026-03-24).

Does Kintor Pharmaceutical Limited pay a dividend?

Dividend yield is not available in the current snapshot for Kintor Pharmaceutical Limited (KNTPF). Check the MyAverix Finance app for the latest dividend data.

What sector is Kintor Pharmaceutical Limited in?

Kintor Pharmaceutical Limited (KNTPF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KNTPF listed on?

KNTPF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)